- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02285127
Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study
May 11, 2023 updated by: Stephen A. Sems, Mayo Clinic
Is there a functional outcome difference when treating pertrochanteric fractures with a short or long cephalomedullary nail?
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
168
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion criteria
- AO/OTA fracture classification 31(A-B) (1-3).
- Age greater than 18 years old.
Exclusion Criteria
-Less than 18 years old.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Short nail implant
used to treat pertrochanteric fractures
|
Biomet Affixus Short and Long hip fracture nail.
Stryker Gamma Short and Long hip fracture nail.
|
|
Active Comparator: Long nail implant
used to treat pertrochanteric fractures
|
Biomet Affixus Short and Long hip fracture nail.
Stryker Gamma Short and Long hip fracture nail.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
SF (short form)-36
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Harris Hip Score
Time Frame: 3 months
|
3 months
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mortality
Time Frame: 1 year
|
1 year
|
|
Reoperation
Time Frame: within 1 year
|
within 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephen Sems, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
May 1, 2018
Study Completion (Actual)
September 1, 2019
Study Registration Dates
First Submitted
November 4, 2014
First Submitted That Met QC Criteria
November 4, 2014
First Posted (Estimate)
November 6, 2014
Study Record Updates
Last Update Posted (Actual)
May 12, 2023
Last Update Submitted That Met QC Criteria
May 11, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-002490
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pertrochanteric Hip Fracture
-
Ilocos Training and Regional Medical CenterUnknownIntertrochanteric Fractures | Pertrochanteric Fracture | Pertrochanteric Fracture of Femur, Closed | Pertrochanteric Fracture of Femur, Open
-
Fundación Universidad Católica de Valencia San...CompletedPertrochanteric Fracture of Femur | Unstable Throchanteric Hip FracturesSpain
-
Milton S. Hershey Medical CenterWithdrawnPertrochanteric Fracture of Femur, Closed
-
Orthofix s.r.l.CompletedHip Fractures | Intertrochanteric Fractures | Pertrochanteric Fracture | Subtrochanteric FracturesItaly
-
King Chulalongkorn Memorial HospitalCompletedPertrochanteric Fracture of Femur, Closed | Unstable Intertrochanteric FractureThailand
-
Orthofix s.r.l.CompletedPertrochanteric Fracture of Femur | Intertrochanteric Fracture of Femur | Subtrochanteric Fracture of FemurItaly
-
Medical University of WarsawCompletedFemoral Neck Fractures | Bone Loss | Bone Resorption | Muscle Loss | Muscle Damage | Pertrochanteric FracturePoland
-
AO Clinical Investigation and Publishing DocumentationCompletedPertrochanteric Fractures of Femur | Intertrochanteric Fractures of the FemurAustria, Switzerland
-
Aarhus University HospitalCompletedPertrochanteric FractureDenmark
-
Tamas IllesCompleted
Clinical Trials on Short versus long cephalomedullary Intramedullary nail
-
National Taiwan University HospitalNational Taiwan University Hospital Hsin-Chu Branch; National Taiwan University...Not yet recruitingBone Metastases | Pathological Fracture | Pathological Fracture, Left Femur | Pathological Fracture, Right Femur
-
Novindiet ClinicTehran University of Medical Sciences; University of NottinghamCompletedObesity | OverweightIran, Islamic Republic of
-
Vestre Viken Hospital TrustRecruiting
-
Helsinki University Central HospitalRecruitingBoth Bone Forearm Fracture | AO Classification 22D/2.1-5.2 | 7-12 Year OldFinland